Q4 2024 Management View CEO Martin Lyons highlighted strong operational and financial results for 2024, including adjusted earnings of $4.63 per share, exceeding the midpoint of their guidance range.

Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...

SAN FRANCISCO-- ( BUSINESS WIRE )-- 6sense ®, the leading platform revolutionizing B2B revenue generation, today released its ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Operator: Welcome to the Northeast Bank Second Quarter Fiscal Year 2025 Earnings Call. My name is Didi, and I will be your operator for today ...

i3 Verticals, Inc. (NASDAQ: IIIV) Q1 2025 Earnings Call Transcript February 7, 2025 ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...

Deckers Outdoor (DECK) shares plunged Friday, despite the shoemaker reporting sales results for the latest ... “Hoka has a robust new product pipeline,” the UBS note said, while calling ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) ("Brookfield Renewable Partners”, "BEP") today reported financial results for the three and twelve months ended December 31, 2024. "2024 was ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...